Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A27121 | 19137963 | Ned Tijdschr Geneeskd | [The practice guideline 'Viral hepatitis and other liver diseases' (second revision) from the Dutch College of General Practitioners; a response from the perspective of general practice]. | 2008 | Details |
A27122 | 19137372 | Mamm Genome | Genetic factors for resistance to diet-induced obesity and associated metabolic traits on mouse chromosome 17. | 2009 | Details |
A27123 | 19135440 | Eur J Pharmacol | Comparative therapeutic effects of metformin and vitamin E in a model of non-alcoholic steatohepatitis in the young rat. | 2008 | Details |
A27124 | 19131466 | Diabetes Care | Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis. | 2009 | Details |
A27126 | 19119140 | J Biol Chem | Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase. | 2009 | Details |
A27127 | 19118644 | Clin Gastroenterol Hepatol | Noninvasive assessment of hepatic steatosis. | 2008 | Details |
A27128 | 19117027 | Diabetes Metab Res Rev | The roles of obesity and gender on the relationship between metabolic risk factors and non-alcoholic fatty liver disease in Koreans. | 2009 | Details |
A27129 | 21686813 | BMJ Case Rep | Non-alcoholic fatty liver disease in a patient with maturity onset diabetes in the young. | 2009 | Details |
A27130 | 21180532 | Therap Adv Gastroenterol | Current status of therapy in nonalcoholic Fatty liver disease. | 2009 | Details |
A27131 | 21179914 | Rom J Intern Med | Liver biopsy versus noninvasive methods--fibroscan and fibrotest in the diagnosis of non-alcoholic fatty liver disease: a review of the literature. | 2009 | Details |
A27132 | 20948730 | F1000 Med Rep | Is there an effective therapy available for non-alcoholic fatty liver disease? | 2009 | Details |
A27133 | 20469684 | Eksp Klin Gastroenterol | [Obesity as a risk factor of non-alcoholic fatty gallbladder disease (cholicyststeatosis, steatocholecystitis)]. | 2009 | Details |
A27134 | 20469674 | Eksp Klin Gastroenterol | [Non-alcoholic fatty liver disease: age peculiarities, breakthrough in pathogenetic therapy]. | 2009 | Details |
A27135 | 20469672 | Eksp Klin Gastroenterol | [Non-alcoholic fatty liver disease in dyslipidemia and insulin resistance: similarities and differences; differential approach to therapy]. | 2009 | Details |
A27136 | 20387270 | J Alzheimers Dis | Nitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's disease. | 2009 | Details |
A27137 | 19115316 | Hepatology | VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice. | 2009 | Details |
A27138 | 19110662 | Turk J Gastroenterol | Factors related to non-alcoholic fatty liver disease in obese children. | 2008 | Details |
A27139 | 19107341 | J Gastroenterol | Etiology of non-B non-C hepatocellular carcinoma in the eastern district of Tokyo. | 2008 | Details |
A27140 | 19105201 | Hepatology | Transcription factor 7-like 2 polymorphism modulates glucose and lipid homeostasis, adipokine profile, and hepatocyte apoptosis in NASH. | 2009 | Details |
A27141 | 19104698 | J Gastrointestin Liver Dis | Improving nonalcoholic fatty liver disease management by general practitioners: a critical evaluation and impact of an educational training program. | 2008 | Details |
A27142 | 19098851 | Am J Gastroenterol | The histologic spectrum of liver disease in African-American, non-Hispanic white, and Hispanic obesity surgery patients. | 2009 | Details |
A27143 | 19093069 | J Hepatobiliary Pancreat Surg | Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases. | 2008 | Details |
A27145 | 19088402 | Endocr J | A novel mouse model for type 2 diabetes and non-alcoholic fatty liver disease: spontaneous amelioration of diabetes by augmented beta cell mass. | 2008 | Details |
A27146 | 19087776 | Cir Esp | [Prevalence and associated factors to non-alcoholic steatohepatitis in obese patients subjected to bariatric surgery]. | 2008 | Details |
A27148 | 19084941 | World J Gastroenterol | Inhibition of hepatic interleukin-18 production by rosiglitazone in a rat model of nonalcoholic fatty liver disease. | 2008 | Details |
A27149 | 19077512 | Korean J Gastroenterol | [Clinical characteristics of health screen examinees with nonalcoholic fatty liver and normal liver function test]. | 2008 | Details |
A27150 | 19077235 | BMC Endocr Disord | The Edinburgh Type 2 Diabetes Study: study protocol. | 2008 | Details |
A27151 | 19075784 | Endocr Metab Immune Disord Drug Targets | Does non-alcoholic fatty liver disease (NAFLD) increase cardiovascular risk? | 2008 | Details |
A27152 | 19074370 | J Lipid Res | Nonalcoholic fatty liver disease. | 2008 | Details |
A27153 | 19074179 | Gut | High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease. | 2008 | Details |
A27154 | 19073452 | Orv Hetil | [Silymarin in the treatment of chronic liver diseases: past and future]. | 2008 | Details |
A27155 | 19072834 | Hepatology | Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist. | 2009 | Details |
A27156 | 19072371 | Expert Rev Gastroenterol Hepatol | Nonalcoholic fatty liver disease: from clinical recognition to treatment. | 2008 | Details |
A27157 | 19072356 | Expert Rev Gastroenterol Hepatol | Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C. | 2008 | Details |
A27158 | 19072347 | Expert Rev Gastroenterol Hepatol | Role of nonalcoholic fatty liver disease in the development of insulin resistance and diabetes. | 2008 | Details |
A27159 | 19070395 | J Hepatol | Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis. | 2008 | Details |
A27160 | 18973845 | Gastroenterol Clin Biol | FibroMeters: a family of blood tests for liver fibrosis. | 2008 | Details |
A27161 | 18973844 | Gastroenterol Clin Biol | FibroTest-ActiTest as a non-invasive marker of liver fibrosis. | 2008 | Details |
A27162 | 19067776 | J Gastroenterol Hepatol | Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors. | 2008 | Details |
A27163 | 19065650 | Hepatology | Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management. | 2009 | Details |
A27164 | 19058085 | Scand J Gastroenterol | Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol. | 2009 | Details |
A27165 | 19056644 | J Nutr | Impaired sulfur-amino acid metabolism and oxidative stress in nonalcoholic fatty liver are alleviated by betaine supplementation in rats. | 2008 | Details |
A27166 | 19055132 | Ned Tijdschr Geneeskd | [Liver cirrhosis in diabetes mellitus; a complication not always recognized]. | 2008 | Details |
A27167 | 19054294 | J Paediatr Child Health | The population prevalence of adverse concentrations and associations with adiposity of liver tests among Australian adolescents. | 2008 | Details |
A27168 | 19054139 | Hepatol Res | Analysis of hepatic genes involved in the metabolism of fatty acids and iron in nonalcoholic fatty liver disease. | 2008 | Details |
A27169 | 19053946 | Clin Sci (Lond) | Magic angle spinning magnetic resonance: a novel method opening up translational research into NAFLD? | 2009 | Details |
A27170 | 19052646 | PLoS One | Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers. | 2008 | Details |
A27171 | 19051794 | Ned Tijdschr Geneeskd | [Non-alcoholic fatty liver disease in children: a new complication of obesity]. | 2008 | Details |
A27172 | 19049831 | Clin Gastroenterol Hepatol | Long-term follow-up of patients with nonalcoholic fatty liver. | 2008 | Details |
A27173 | 19038040 | J Transl Med | Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign? | 2008 | Details |
A27174 | 19035982 | Aliment Pharmacol Ther | Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels. | 2008 | Details |
A27175 | 19034968 | World J Gastroenterol | Innate immune reactivity of the liver in rats fed a choline-deficient L-amino-acid-defined diet. | 2008 | Details |
A27176 | 19034256 | Minerva Med | Nonalcoholic fatty liver disease. | 2008 | Details |
A27177 | 19034237 | Ann Hepatol | Nonalcoholic fatty liver disease in severely obese individuals: the influence of bariatric surgery. | 2009 | Details |
A27178 | 19034235 | Ann Hepatol | AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis. | 2009 | Details |
A27179 | 19032865 | Zhonghua Gan Zang Bing Za Zhi | [Expression and action of hepatic sterol regulatory element-binding protein-1c in patients with nonalcoholic fatty liver disease]. | 2008 | Details |
A27180 | 19032450 | J Gastroenterol Hepatol | Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C. | 2008 | Details |
A27181 | 19027869 | Int J Biochem Cell Biol | Non-alcoholic steatohepatitis and animal models: understanding the human disease. | 2008 | Details |
A27182 | 19025953 | J Magn Reson Imaging | Evaluating the severity of nonalcoholic steatohepatitis with superparamagnetic iron oxide-enhanced magnetic resonance imaging. | 2008 | Details |
A27183 | 19025308 | Rev Esp Enferm Dig | [Molecular basis of obesity-related hepatic steatosis]. | 2008 | Details |
A27184 | 19022218 | Arch Biochem Biophys | PKCepsilon plays a causal role in acute ethanol-induced steatosis. | 2008 | Details |
A27185 | 19017926 | Radiology | Nonalcoholic fatty liver disease: rapid evaluation of liver fat content with in-phase and out-of-phase MR imaging. | 2008 | Details |
A27186 | 19016656 | Clin Sci (Lond) | Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis. | 2008 | Details |
A27187 | 19016382 | Scand J Gastroenterol | Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease. | 2009 | Details |
A27189 | 19015052 | J Chin Med Assoc | Effects of therapeutic lifestyle program on ultrasound-diagnosed nonalcoholic fatty liver disease. | 2008 | Details |
A27190 | 19014878 | J Hepatol | Epidemiology of non-alcoholic fatty liver disease in China. | 2008 | Details |
A27191 | 19014569 | BMC Gastroenterol | Plasma Pentraxin3 is a novel marker for nonalcoholic steatohepatitis (NASH). | 2008 | Details |
A27192 | 19013572 | Atherosclerosis | Factors associated with insulin resistance and non-alcoholic fatty liver disease among youths. | 2008 | Details |
A27193 | 19013463 | Gastroenterology | Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis. | 2008 | Details |
A27194 | 19010326 | Gastroenterology | Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. | 2008 | Details |
A27195 | 19009658 | World J Gastroenterol | Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia. | 2008 | Details |
A27196 | 19005759 | Dig Dis Sci | Influence of visfatin on histopathological changes of non-alcoholic fatty liver disease. | 2008 | Details |
A27197 | 19004189 | Adv Clin Chem | Biomarkers of liver fibrosis. | 2008 | Details |
A27198 | 19002423 | Internist (Berl) | [Are there therapeutic approaches of non-alcoholic fatty liver disease and its complications?]. | 2008 | Details |
A27199 | 19001666 | J Lipid Res | Effect of dietary monosodium glutamate on trans fat-induced nonalcoholic fatty liver disease. | 2008 | Details |
A27200 | 18997102 | Exp Biol Med (Maywood) | Hyperlipidemic chicken as a model of non-alcoholic steatohepatitis. | 2008 | Details |
A27201 | 18995215 | Clin Gastroenterol Hepatol | Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients. | 2008 | Details |
A27202 | 18992746 | Gastroenterology | Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease. | 2008 | Details |
A27203 | 18990087 | Biochem J | Viral hepatitis and fatty liver disease: how an unwelcome guest makes pâté of the host. | 2008 | Details |
A27204 | 18989777 | Dig Dis Sci | Diagnostic value of serum prolidase enzyme activity to predict the liver histological lesions in non-alcoholic fatty liver disease: a surrogate marker to distinguish steatohepatitis from simple steatosis. | 2008 | Details |
A27205 | 18989145 | Eur J Gastroenterol Hepatol | Treatment of preestablished diet-induced fatty liver by oral fatty acid-bile acid conjugates in rodents. | 2008 | Details |
A27206 | 18986848 | Clin Gastroenterol Hepatol | Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. | 2008 | Details |
A27207 | 18984944 | Respiration | Continuous positive airway pressure and liver enzymes in obstructive sleep apnoea: data from a randomized controlled trial. | 2008 | Details |
A27208 | 18984463 | Clin Liver Dis | The global impact of hepatic fibrosis and end-stage liver disease. | 2008 | Details |
A27209 | 18980719 | Clin Invest Med | Non-alcoholic fatty liver disease, obesity and other illnesses. | 2008 | Details |
A27211 | 18977552 | J Hepatol | Comparison of blood tests for liver fibrosis specific or not to NAFLD. | 2008 | Details |
A27212 | 18976012 | Arch Pathol Lab Med | Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis? | 2008 | Details |
A27213 | 18972405 | Hepatology | Role of leisure-time physical activity in nonalcoholic fatty liver disease: a population-based study. | 2008 | Details |
A27214 | 18972077 | Adv Ther | Angiotensin receptor blockers in the treatment of NASH/NAFLD: could they be a first-class option? | 2008 | Details |
A27215 | 18957882 | Curr Opin Lipidol | The trials and tribulations of the treatment of nonalcoholic fatty-liver disease. | 2008 | Details |
A27216 | 18956298 | Semin Liver Dis | Effects of weight loss on nonalcoholic fatty liver disease. | 2008 | Details |
A27217 | 18956297 | Semin Liver Dis | Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery. | 2008 | Details |
A27218 | 18956296 | Semin Liver Dis | Current and emerging therapies in nonalcoholic fatty liver disease. | 2008 | Details |
A27219 | 18956295 | Semin Liver Dis | Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive. | 2008 | Details |
A27220 | 18956294 | Semin Liver Dis | Hepatic, cardiovascular, and endocrine outcomes of the histological subphenotypes of nonalcoholic fatty liver disease. | 2008 | Details |
A27221 | 18956293 | Semin Liver Dis | Mechanisms of disease progression in nonalcoholic fatty liver disease. | 2008 | Details |
A27222 | 18956292 | Semin Liver Dis | Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. | 2008 | Details |
A27223 | 18956291 | Semin Liver Dis | Abnormalities of lipid metabolism in nonalcoholic fatty liver disease. | 2008 | Details |
A27224 | 18956290 | Semin Liver Dis | The epidemiology of nonalcoholic fatty liver disease: a global perspective. | 2008 | Details |
A27225 | 18955783 | J Korean Med Sci | Impact of visceral fat on the metabolic syndrome and nonalcoholic fatty liver disease. | 2008 | Details |